Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,097,297 | 5,585,298 | 6,636,904 | 6,059,566 | 6,586,191 |
| Marketable Securities | 191,820 | 262,604 | 332,049 | 313,879 | 977,167 |
| Receivables | 8,174,090 | 7,990,854 | 8,473,336 | 9,522,738 | 8,607,966 |
| Inventories | 7,344,148 | 6,710,038 | 6,914,741 | 7,056,361 | 7,883,341 |
| Other current assets | 198,215 | 245,266 | 291,391 | 177,296 | 166,445 |
| TOTAL | $21,005,570 | $20,794,060 | $22,648,420 | $23,129,840 | $24,221,110 |
| Non-Current Assets | |||||
| PPE Net | 13,634,570 | 13,392,820 | 14,648,080 | 14,408,210 | 15,122,410 |
| Investments And Advances | 1,615,124 | 1,641,277 | 1,691,414 | 1,578,587 | 2,281,491 |
| Intangibles | 31,111,923 | 30,611,992 | 33,531,474 | 31,960,464 | 34,529,430 |
| Other Non-Current Assets | 7,101,173 | 6,934,251 | 7,553,082 | 6,127,869 | 6,534,539 |
| TOTAL | $53,462,790 | $52,580,340 | $57,424,050 | $54,075,130 | $58,467,870 |
| Total Assets | $74,468,360 | $73,374,390 | $80,072,480 | $77,204,970 | $82,688,980 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,455,426 | 4,632,738 | 5,596,034 | 5,201,981 | 6,435,526 |
| Accounts payable and accrued liabilities | 25,038,900 | 14,905,280 | 16,214,810 | 15,384,000 | 15,611,710 |
| Accrued Expenses | 1,188,005 | 1,751,522 | 1,768,667 | 1,755,882 | 1,634,351 |
| Other current liabilities | 2,131,760 | 1,944,759 | 2,172,545 | 1,477,463 | 2,300,145 |
| TOTAL | $36,814,090 | $23,234,300 | $25,752,050 | $23,819,320 | $25,981,730 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,676,810 | 18,085,020 | 19,870,050 | 20,226,130 | 21,664,120 |
| Other Non-Current Liabilities | 13,679,328 | 22,473,735 | 25,028,296 | 25,502,974 | 26,607,350 |
| TOTAL | $31,996,860 | $43,212,050 | $47,594,070 | $48,135,070 | $50,643,360 |
| Total Liabilities | $68,810,950 | $66,446,340 | $73,346,130 | $71,954,390 | $76,625,090 |
| Shareholders' Equity | |||||
| Common Shares | 1,717,428 | 1,663,574 | 1,818,813 | 1,761,135 | 1,924,201 |
| Retained earnings | -7,486,095 | -6,077,062 | -7,307,778 | -8,602,115 | -8,725,627 |
| Other shareholders' equity | 7,579,448 | 7,631,631 | 8,211,763 | 8,276,417 | 8,765,804 |
| TOTAL | $5,657,411 | $6,928,049 | $6,726,354 | $5,250,573 | $6,063,887 |
| Total Liabilities And Equity | $74,468,361 | $73,374,389 | $80,072,484 | $77,204,963 | $82,688,977 |